Previous 10 | Next 10 |
PRA Health Sciences (NASDAQ: PRAH ): Q1 Non-GAAP EPS of $1.05 beats by $0.05 ; GAAP EPS of $0.63 beats by $0.05 . More news on: PRA Health Sciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Net new business of $604.7 million; Net book-to-bill of 1.10 excluding reimbursement revenue Net new business of $955.9 million; Net book-to-bill of 1.32 including reimbursement revenue $783.7 million of total revenue; representing 8.5% growth at actual foreign exchange rates and 9....
RALEIGH, N.C., April 13, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2020 results after the market closes on Thursday, April 30, 2020. The Company will also host a conference call on Friday, May 1, 2020 at 9:00 a.m. (ET) to discuss t...
Metys COVID-19 Module delivers pharmaceutical market analytics and intelligence quickly through a single access point RALEIGH, N.C., April 08, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day ...
PRA Health Sciences (NASDAQ: PRAH ) has expanded its Mobile Health Platform for remote clinical monitoring, adding new capabilities that address sponsor needs for COVID-19 virtual study support. More news on: PRA Health Sciences, Inc., Diffusion Pharmaceuticals Inc., Bruker Corporation, ...
PRA’s Mobile Health Platform delivers virtual solutions for sites and patients enrolled in trials RALEIGH, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- As a response to the ongoing global COVID-19 pandemic, PRA Health Sciences announced today the expansion of its industry-leading Mobile ...
Three-tiered, mobile-app driven program tracks individuals’ physical and psychological symptoms from COVID-19 RALEIGH, N.C., March 20, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tie...
Business disruptions due to COVID-19 represent a new risk for investors across all sectors. Expect to see language addressing this added to the risk factors section of 10-K annual reports filed with the Securities and Exchange Commission (SEC). For biotech and pharma companies, COVID-19 will im...
RALEIGH, N.C., March 11, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today a partnership between Symphony Health and Datavant that expands the breadth of data available for integration and allows life sciences companies to get the deepest and most holistic view of ...
Image source: The Motley Fool. PRA Health Sciences Inc (NASDAQ: PRAH) Q4 2019 Earnings Call Feb 21, 2020 , 9:00 a.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...